Burcon NutraScience Corporation develops plant protein extraction and purification technology in the field of functional and renewable plant proteins. The company's patented processes utilize oilseed for the production of purified plant proteins that exhibit nutritional, functional, and nutraceutical profiles. Its products include CLARISOY, a soy protein that offers clarity and protein nutrition for low and neutral pH beverage systems; Peazazz, a pea protein, which is soluble with clean flavor characteristics; and Puratein, Supertein, and Nutratein that are canola protein isolates with functional and nutritional attributes. The company's products are targeted at protein ingredient market, and for health and wellness applications. Its patent portfolio consists of 216 issued patents in various countries. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:BU
CUSIPN/A
Phone+1-604-7330896
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-10,747.86%
Return on Equity-630.98%
Return on Assets-159.82%
Miscellaneous
EmployeesN/A
Outstanding Shares43,942,000
Market CapC$22.70 million
Burcon NutraScience (TSE:BU) Frequently Asked Questions
What is Burcon NutraScience's stock symbol?
Burcon NutraScience trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BU."
How were Burcon NutraScience's earnings last quarter?
Burcon NutraScience Corp (TSE:BU) announced its earnings results on Monday, June, 18th. The company reported ($0.03) earnings per share for the quarter. The business had revenue of $0.15 million for the quarter. Burcon NutraScience had a negative return on equity of 630.98% and a negative net margin of 10,747.86%. View Burcon NutraScience's Earnings History.
When is Burcon NutraScience's next earnings date?
Who are some of Burcon NutraScience's key competitors?
Some companies that are related to Burcon NutraScience include 4d Pharma (DDDD), Helix Biopharma (HBP), Ergomed (ERGO), Cardiome Pharma (COM), GB Sciences (GBLX), OncoCyte (OCX), InMed Pharmaceuticals (IMLFF), Navidea Biopharmaceuticals (NAVB), Botanix Pharmaceuticals (BOT), IntelGenx Technologies (IGX), BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Destiny Pharma (DEST), NovaBay Pharmaceuticals (NBY) and Rexahn Pharmaceuticals (RNN).
Who are Burcon NutraScience's key executives?
Burcon NutraScience's management team includes the folowing people:
- Dr. Allan Yap, Chairman & CEO (Age 62)
- Mr. Johann Franz Tergesen MBA, CPA, CA, Pres & COO (Age 55)
- Ms. Jade Cheng MBA, CPA, CA, CFO & Treasurer
- Dr. Martin Hans Schweizer, VP of Technical Devel.
- Ms. Kam T. Law B.Comm., L.L.B., Sr. VP of Legal & Corp. Sec. (Age 49)
Has Burcon NutraScience been receiving favorable news coverage?
News stories about BU stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Burcon NutraScience earned a daily sentiment score of 0.05 on Accern's scale. They also gave media coverage about the company an impact score of 46.62 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Burcon NutraScience.
How do I buy shares of Burcon NutraScience?
Shares of BU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Burcon NutraScience's stock price today?
One share of BU stock can currently be purchased for approximately C$0.40.
How big of a company is Burcon NutraScience?
Burcon NutraScience has a market capitalization of C$22.70 million.
How can I contact Burcon NutraScience?
Burcon NutraScience's mailing address is 1946 Broadway W, VANCOUVER, BC V6J 1Z2, Canada. The company can be reached via phone at +1-604-7330896.
MarketBeat Community Rating for Burcon NutraScience (TSE BU)
MarketBeat's community ratings are surveys of what our community members think about Burcon NutraScience and other stocks. Vote "Outperform" if you believe BU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BU will underperform the S&P 500 over the long term. You may vote once every thirty days.
